Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 29 Nov 2023 10:06 CET |
PHOTOCURE | Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 20 Nov 2023 17:50 CET |
PHOTOCURE | Photocure to present at four investor conferences in November/December 2023 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 Nov 2023 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 01 Nov 2023 08:22 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2023 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Oct 2023 10:32 CEST |
PHOTOCURE | Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 Oct 2023 15:44 CEST |
PHOTOCURE | Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 06 Oct 2023 15:07 CEST |
PHOTOCURE | New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 02 Oct 2023 13:29 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 27 Sep 2023 18:06 CEST |
PHOTOCURE | Photocure ASA: Change of Board Composition | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |